Market Update (NYSE:MDT): Medtronic Receives FDA Approval for Two-Level Prestige LP(TM) Cervical Disc Procedures
July 18, 2016 at 09:02 AM EDT
[GlobeNewswire] – Two-Level Use of Prestige LP Cervical Disc Exhibited Statistical Superiority in Overall Success at 24 Months Compared to Patients Treated with Two-Level Fusion DUBLIN – July 18, 2016 – Medtronic plc (NYSE: … Read more on this. , with a current value of $recting to http://finance.ya, ended trading yesterday at $. Today’s price range has been between $ per share and has traded between $ over the past year. MDT shares are currently priced at x this year’s forecasted earnings, which makes them relatively inexpensive compared to the industry’s x earnings multiple. In a review of the consensus earnings estimate this quarter, 0 sell-side analysts are looking at $ per share, which would be $0.00 worse than the year-ago quarter and a $0.00 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $ is a $0.00 setback when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $0.00 . If reported, that would be a 0.00% decrease over the year-ago quarter. In terms of ratings, d MDT from to (/fi). Previously, d MDT from to . The average price target for MDT shares is $, which is 0.00% below where the stock opened this morning. See more in (NYSE:MDT) Similar Articles: Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Launches Revamped Minimally Invasive Spine Fusion Procedures Market Update (NYSE:MDT): Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths Market Update: Medtronic Inc (NYSE:MDT) – Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators